Draig Therapeutics closes an oversubscribed $65 million Series B round led by Deep Track Capital to accelerate the development of neuropsychiatric therapies.
Amount Raised
$65 Million
Round Type
Series B
CardiffBiotechnologyHealth CareTherapeuticsresearchInvestors
Description
Draig Therapeutics, a clinical-stage biopharmaceutical company, has closed an oversubscribed $65 million Series B financing. This round aims to accelerate the development of specific AMPA and GABAA receptor modulators for neuropsychiatric disorders. The financing was led by Deep Track Capital, with participation from several notable investors.
Quick answer
Draig Therapeutics raised $65 Million in a Series B round, dated July 14, 2026. Investors: Janus Henderson Investors, Marshall Wace, British Business Bank, Jefferson Life Sciences and Deep Track Capital. Draig Therapeutics is based in Cardiff, Wales, United Kingdom.
- How much did Draig Therapeutics raise?
- Draig Therapeutics raised $65 Million in a Series B round on July 14, 2026.
- Who invested in Draig Therapeutics?
- Janus Henderson Investors, Marshall Wace, British Business Bank, Jefferson Life Sciences and Deep Track Capital are named as investors in this round.
- What does Draig Therapeutics do?
- Draig Therapeutics is a clinical-stage company focused on transforming the treatment of neuropsychiatric diseases through its innovative pipeline of next-generation therapies.
- Where is Draig Therapeutics based and how big is it?
- Draig Therapeutics is based in Cardiff, Wales, United Kingdom. Fundz records about 29 employees.
Source: Fundz verified event record.
Who else raised in Therapeutics and research around the same time
Companies in the same sectors as Draig Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- BioLineRx Ltd raised $3.8M on August 27, 2026.
- AusperBio raised $120M (Series C) on August 28, 2026.
- Redx raised $36M (Series A) on August 27, 2026.
- Airway Therapeutics, LLC raised $50M (Series E) on August 25, 2026.
- Revier Therapeutics raised $7M (Seed) on August 25, 2026.
- Amylyx Pharmaceuticals raised $500M (Post-IPO Equity) on August 20, 2026.
Who to call at Draig Therapeutics, and when
A new round usually means Draig Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Draig Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Draig Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Draig Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Draig Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansDraig Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.